Moon J. Noh, Ph.D.
Chief Executive Officer
- TG-C US FDA 임상1, 2상 완료
- 서울대 미생물학 학사 ('89) / 카이스트 생명과학 박사 ('95)
Sung Han, Ph,D.
Chief Executive Officer
- 코오롱인더스트리 미래기술원장 ('18~현재)
- Eastman Chemical Company, Technology Director ('14~'17)
- BS-Material Science & Engineering and Nuclear Engineering, University of California, Berkeley, CA
- PhD-Nuclear Engineering, University of California, Berkeley, CA
김정인
Chief Financial Officer
- Kolon TissueGene, Inc.('21~현재)
- ㈜ 코오롱 경영관리실('13~'21)
- 국민대학교 수학과 학사('02)
이장익, Ph.D.
Outside Director
- Kolon TissueGene, Inc. 사외이사 ('17~현재)
- 서울대학교 약학교수 ('15~현재)
- 연세대학교 약학교수 ('12~'15)
- Clinical Pharmacology Team Leader, CDER, FDA ('01~'12)
- Ph.D. Pharmacy, University of Pittsburgh ('01)
- 서울대학교 약학과 ('84)
Young J. Kim, Ph.D.
Statutory Auditor
- Kolon TissueGene, Inc. 상근감사 ('17~현재)
- Young Enterprise System, Inc. ('99~'16)
- TRW System & Information Technology Group ('94~'99)
- Martin Marietta Corp ('93~'94)
- ITC Corporation ('91~'93)
- Doctorate in Engineering Management at George Washington University